Immunobiology and therapeutic applications of protein C/protein S/thrombomodulin in human and experimental allotransplantation and xenotransplantation

Trends in Cardiovascular Medicine

Volumn 7, Issue 5, 1997, Pages 174-183

  Hancock, Wayne W ^a   Bach, Fritz H ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN C; PROTEIN S; THROMBOMODULIN;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; CELL INFILTRATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENDOTOXEMIA; ENZYME ACTIVATION; GENETIC ENGINEERING; HEART SURGERY; MACROPHAGE ACTIVATION; MONONUCLEAR CELL; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; REVIEW; XENOTRANSPLANTATION;

EID: 0030755533     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(97)00032-7     Document Type: Review

References (33)

1. Aadland E, Odegaard OR, Roseth A, Try K: 1992. Free protein-S deficiency in patients with chronic inflammatory bowel disease. Scand J Gastroenterol 27:957-962.
2. Aoki Y, Ohishi R, Takei R, et al.: 1994. Effects of recombinant human soluble thrombomodulin on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III. Thromb Haemost 71:452-455.
3. Bach FH, Winkler H, Ferran C, Wrighton C, Robson SC, Hancock WW: 1995. Endothelial activation is a barrier to xenotransplantation. Nat Med 1:869-873.
4. Bach FH, Winkler H, Ferran C, Hancock WW, Robson SC: 1996. Delayed xenograft rejection. Immunol Today 17:379-384.
5. Blakely ML, van der Werf W, Berndt M, Dalmasso A, Bach FH, Hancock WW: 1994. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 58:1059-1066.
6. Candinas D, Koyamada N, Miyatake T, Hechenleitner P, Bach FH, Hancock WW: 1996. T cell-independence of macrophage and NK cell infiltration, cytokine production and endothelial activation during delayed xenograft rejection. Transplantation 62:1920-1926.
7. Cirino G, Cicala C, Bucxci MR, Sorrentino L, Maraganore JM, Stone SR: 1996. Thrombin functions as an inflammatory mediator through activation of its receptor. J Exp Med 183:821-827.
8. Conway EM, Rosenberg RD: 1988. Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol Cell Biol 8:5588-5593.
9. Esmon CT, Fukudome K: 1995. Cellular regulation of the protein C pathway. Semin Cell Biol 6:259-268.
10. Fukudome K, Esmon CT: 1994. Identification, cloning and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem 269:26,486-26,491.
11. Godowski PJ, Mark MR, Chen JA, Sadick MD, Raab H, Hammond RG: 1995. Reevaluation of the roles of protein S and Gas6 as ligands for the receptor tyrosine kinase Rse/Tyro 3. Cell 82:355-358.
12. Grey S, Tsuchida A, Hau H, Orthner CL, Salem HH, Hancock WW: 1994. Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-γ or phorbol ester. J Immunol 153:3664-3672.
13. Grey ST, Hancock WW: 1996. A physiologic anti-inflammatory pathway based upon thrombomodulin expression and generation of activated protein C by human mononuclear phagocytes. J Immunol 156:2256-2263.
14. Hancock WW: 1984. Analysis of intragraft effector mechanisms associated with human renal allograft rejection: immunohistological studies using monoclonal antibodies. Immunol Rev 77:61-84.
15. Hancock WW: 1997'a. The past, present and future of renal xenotransplantation. Kidney Int 51:932-944.
16. Hancock WW: 1997b. Immunopathology of discordant xenograft rejection. In Cooper DKC, ed. Xenotransplantation. Berlin, Springer-Verlag pp. 303-313.
17. Hancock WW, Salem H: 1993. Activated protein C blocks endotoxin-induced renal injury: reduced cytokine expression, endothelial activation, fibrin deposition and cell infiltration [abst]. J Am Soc Nephrol 4:605.
18. Hancock WW, Gee D, de Moerloose P, Rickles FR, Ewan VA, Atkins RC: 1985. Immunohistological analysis of serial biopsies taken during human renal allograft rejection: changing profile of infiltrating cells and involvement of the coagulation system. Transplantation 39: 430-438.
19. Hancock WW, Tanaka K, Salem H, Tilney NL, Kupiec-Weglinski J: 1991. TNF as a mediator of cardiac rejection and effects on the protein C/protein S/thrombomodulin pathway. Transplant Proc 23:235-237.
20. Hancock WW, Sayegh MH, Sablinski T, Kut JP, Kupiec-Weglinski JW, Milford EL: 1992a. Blocking of mononuclear cell accumulation, cytokine production and endothelial activation within rat cardiac allografts by CD4 monoclonal antibody therapy. Transplantation 53:1276-1280.
21. Hancock WW, Tsuchida A, Hau H, Thomson NM, Salem HH: 1992b. The anticoagulants protein C and protein S display potent antiinflammatory and immunosuppressive effects relevant to transplant biology and therapy. Transplant Proc 24:2302-2303.
22. Hancock WW, Grey ST, Hau H, Salem HH: 1995a. Binding of the anticoagulant, protein S, to a receptor on human mononuclear phagocytes blocks LPS-induced TNF-a production and modulates CD14 expression [abst]. FASEB J 9:A779.
23. Hancock WW, Grey ST, Hau L, et al.: 1995b. Binding of activated protein C to a specific receptor on human mononuclear phagocytes inhibits intracellular calcium signaling and monocyte-dependent proliferative responses. Transplantation 60:1525-1532.
24. Hancock WW, Sayegh MH, Turka LA: 1996. Blockade of CD40-ligand prevents murine cardiac allograft rejection: differential effects on in vivo expression of B7-1 (CD80) and B7-2 (CD86). Proc Natl Acad Sci USA 93: 13,967-13,972.
25. Murakami K, Okajima K, Uchiba M, Okabe H, Takatsuki K: 1996. Activated protein C attenuates endotoxin-induced pulmonary vascular injury by inhibiting activated leukocytes in rats. Blood 87:642-647.
26. Salom RN, Maguire JA, Esmore D, Hancock WW: 1995. Endothelial cell activation and cytokine expression during acute human cardiac allograft rejection. Transplant Proc 27: 2164-2165.
27. Stitt TN, Conn G, Gore M, et al.: 1995. The anti-coagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases. Cell 80:661-670.
28. Takahashi Y, Hosaka Y, Niina H, et al.: 1995. Soluble thrombomodulin purified from hu-man urine exhibits a potent anticoagulant effect in vitro and in vivo. Thromb Haemost 73:805-811.
29. Taylor F, Chang A, Esmon E, D'Angelo S, Blick K: 1987. Protein C prevents the coagulopathic and lethal effects of E coli infusion in the baboon. J Clin Invest 79:918-927.
30. Tsuchida A, Salem H, Thomson NM, Hancock WW: 1992. Tumor necrosis factor production during human renal allograft rejection is associated with depression of plasma protein C and free protein S levels and decreased intragraft thrombomodulin expression. J Exp Med 175:81-90.
31. Vu TKH, Hung DT, Wheaton VI, Coughlin SR: 1991. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64: 1057-1063.
32. Wright SD: 1991. Multiple receptors for endotoxin. Curr Opin Immunol 3:83-90.
33. Wrighton C, Kopp CW, McShea A, Vetr H, Bach FH: 1995. High level expression of functional human thrombomodulin in cultured porcine aortic endothelial cells. Transplant Proc 27:288-289.